Pharmacokinetic studies in man with a beta-sympathomimetic drug used as aerosol
Seyberth, H.W.; Rahn, K.H.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 888-891
1973
ISSN/ISBN: 0070-4067 PMID: 4151320 Document Number: 65513
Document emailed within 1 workday
Related Documents
Grüneberger, A.; Geier, G. 1981: Treatment of motor urge incontinence with the beta 2-sympathomimetic drug clenbuterol Der Urologe. Ausg. a 20(3): 153-154Yonga, G.O.; Oyuga, H.W.; Njeru, E.K. 1993: Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise East African Medical Journal 70(7): 405-408
Varma, K.J.; Powers, T.E.; Powers, J.D. 1987: Single- and repeat-dose pharmacokinetic studies of chloramphenicol in horses: values and limitations of pharmacokinetic studies in predicting dosage regimens American Journal of Veterinary Research 48(3): 403-406
Jonkman, J.H.; van Lier, J.J.; van Heiningen, P.N.; Lins, R.; Sennewald, R.; Högemann, A. 1997: Pharmacokinetic drug interaction studies with candesartan cilexetil Journal of Human Hypertension 11(Suppl 2): S31-S35
Harada, J.; Goto, Y. 1986: Effects of beta-stimulant aerosol on respiration, circulation and metabolism. Experimental studies of inhalation techniques on canine asthma models Zeitschrift für Erkrankungen der Atmungsorgane 166(1): 110-111
Descotes, J.; Simonet, R.; Loupi, E.; Evreux, J.C. 1986: Drug interactions due to enzymatic inhibition. the predictive value of pharmacokinetic studies Therapie 41(5): 349-351
Losch, K.; Heinze, W.; Mieth, K. 1980: Pharmacokinetic model studies of sulfamerazine in domestic mammals. 6. Absence of drug residues Archiv für Experimentelle Veterinarmedizin 34(4): 583-586
Criée, C.P.; Laier-Groeneveld, G. 1995: Beta 2-sympathomimetic drugs Der Internist 36(9): 918-923
Drabant, S.; Klebovich, I.; Gachályi, B.; Renczes, G.; Farsang, C. 1998: Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets Acta Pharmaceutica Hungarica 68(5): 294-306
Schulz, V.; Ulmer, W.T.; Kleinsorge, H. 1992: Risk-benefit assessment and value of beta-2-sympathomimetic drugs in asthma therapy Pneumologie 46(8): 315-321
Bascuñana, H.; Villarreal, I.; Alfonso, S.; Terré, R.; Bernabeu, M. 2000: Agitation in head injury. II. Treatment with antidepressant, sympathomimetic, beta blocker , dopaminergic and other drugs Revista de Neurologia 30(11): 1044-1047
Migueres, J.; Escamilla, R.; Longhi, R.; Hermant, C.; Massabuau, P.; Bounhoure, J.P.; Keita, B. 1987: Cardiac tolerance of a beta 2-sympathomimetic spray in 37 asthmatic adults monitored by Holter recording Allergie et Immunologie 19(3): 104-109
Kandus, J. 1987: The effect of sympathomimetic and anticholinergic drug overdose on heart function Bratislavske Lekarske Listy 88(5): 532-537
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Marmo, E.; Vacca, C.; Saini, R.K.; Fici, F. 1974: Absorption studies with ritodrine an adrenergic beta stimulant drug Bollettino Chimico Farmaceutico 113(10): 559-561
Nakamura, H.; Iwai, N. 1992: Pharmacokinetic studies on oral antibiotics in pediatrics. V. A pharmacokinetic study on cefdinir in pediatrics Japanese Journal of Antibiotics 45(1): 12-27
Wagner, J.G.; Weidler, D.J.; Lin, Y.J. 1976: New method for detecting and quantitating pharmacokinetic drug-drug interactions applied to ethanol-propranolol Research Communications in Chemical Pathology and Pharmacology 13(1): 9-18
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Koriakin, V.A.; Sokolova, G.B.; Ziia, A.V.; Zeliger, L.R.; Ivleva, A.Ia. 1987: Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients Terapevticheskii Arkhiv 59(7): 75-77